This bulletin provides updates on the COVID-19 patent pool, opposition from leading pharmaceutical companies, and key patent law changes in India and abroad. It includes IPO e-filing developments, WHO C-TAP news, and significant international patent infringement cases.
Read more about COVID-19 patent pool opposed as Pfizer and AstraZeneca see no incentive and other patent news